Online Cardiology CME Available | Login Now!

Dr. Bates, MD, is professor of internal medicine at the University of Michigan. Dr. Bates graduated from Princeton University and the University of Michigan Medical School. He trained in internal medicine and cardiology at the University of Michigan Hospitals. His major clinical interests include acute myocardial infarction, acute coronary syndromes and coronary artery disease. His research efforts have focused on fibrinolytic and catheter-based reperfusion therapy for acute myocardial infarction and cardiogenic shock, antiplatelet and anticoagulant therapy for coronary thrombosis, and coronary artery revascularization. Dr. Bates has served on the steering committees for several important international multicenter randomized clinical trials. He serves on the editorial boards of the American Journal of Cardiology, the European Journal of Cardiology, the Journal of the American College of Cardiology, JACC-Cardiovascular Interventions and the American Heart Journal.

Dr. Beckman's research focuses on the mechanisms that cause vascular dysfunction and susceptibility to atherosclerosis, translating discoveries made at the lab bench to human beings. Dr. Beckman has an ongoing interest in understanding how diabetes impairs vascular function, investigating the salient mediators of hyperglycemia and insulin resistance. More recently, Dr. Beckman has begun investigations into vascular dysfunction in hypertension. These investigations use ultrasound, plethysmography, and laboratory analysis to parse out the mechanisms of vascular dysfunction. Ongoing investigations seek to understand how insulin resistance impairs endothelial cell signaling and vasomotor function, whether atherosclerosis causes insulin resistance and vascular dysfunction, and how resistant hypertension impacts upon the cardiac, vascular, and renal function.

Dr. Berger is associate director of the Electrophysiology Service of The Johns Hopkins Hospital. He is Board-certified in internal medicine, cardiovascular disease and clinical cardiac electrophysiology. He received his undergraduate, master's and doctorate degrees from Massachusetts Institute of Technology in electrical engineering and computer science. He received his medical degree from Harvard Medical School, Division of Health Sciences and Technology, in 1987. Between 1987 and 1990 he was a research fellow and later a research scientist at Harvard-MIT Division of Health Sciences and Technology. Dr. Berger did his internship and residency at Brigham and Women's Hospital in Boston. In 1990 Dr. Berger became a cardiology fellow at Johns Hopkins Hospital. He subsequently became an assistant professor of medicine and an attending electrophysiologist at Hopkins in 1993. In 1996 he was promoted to associate director of the electrophysiology service and in 1998 to his current position as associate professor of medicine.

Deepak Bhatt is Chief of Cardiology for the VA Boston Healthcare System. Dr Bhatt obtained his undergraduate degree from the Massachusetts Institute of Technology, while also serving as a research associate at Harvard Medical School. He received his medical doctorate from Cornell University. His internship and residency in internal medicine were performed at the Hospital of the University of Pennsylvania. His cardiovascular training was completed at the Cleveland Clinic Foundation. He also completed fellowships in interventional cardiology and cerebral and peripheral vascular intervention, as well as serving as chief interventional fellow at the Cleveland Clinic. He is board certified by the American Board of Internal Medicine in internal medicine, cardiovascular diseases, and interventional cardiology. Dr Bhatt is a member of the American Association for the Advancement of Sciences, the American College of Physicians, and the New York Academy of Sciences.

Dr. Calkins is a Professor of Cardiology and Pediatrics at the Johns Hopkins University School of Medicine; and Director of the Arrhythmia Service, the Electrophysiology Lab and the Tilt Table Diagnostic Lab at The Johns Hopkins Hospital. He is Board-certified in internal medicine; cardiovascular disease; and electrophysiology. He received his undergraduate degree from Williams College in Williamstown, Massachusetts, where he graduated magna cum laude with highest honors in chemistry. He received his medical degree from Harvard Medical School. Dr. Calkins performed his internship and residency at Massachusetts General Hospital in Boston. He was a postdoctoral fellow in cardiology at The Johns Hopkins Hospital from 1986-1989. During that time he won first place in the Young Investigator Competition from the North American Pacing and Electrophysiology Society. From 1989 to 1992 he served at the University of Michigan Hospital as an assistant professor of medicine, an attending electrophysiologist and director of the pacemaker service. From 1992 until the present, Dr. Calkins has been with Johns Hopkins. Dr. Calkins has co-authored more than a hundred and fifty articles and book chapters. He also serves on the editorial boards of the Journal of Cardiovascular Electrophysiology and the Journal of Interventional Cardiac Electrophysiology. He is an associate editor of the New England Journal of Medicine publication, Journal Watch for Cardiology. His research is focused on the areas of catheter ablation, syncope, arrhythmogenic right ventricular dysplasia, as well as device therapy for treatment of ventricular arrhythmias.

Dr. Alan Cheng graduated summa cum laude, Phi Beta Kappa from the University of California, Los Angeles with a B.S. degree in Biochemistry. He later matriculated to Yale Medical School where he earned his MD degree. He served as an intern and a resident in internal medicine on the Osler Medical Service at The Johns Hopkins Hospital. He remained at Hopkins for his general cardiology and advanced cardiac electrophysiology training. Currently, he is on staff as an Assistant Professor of Medicine at the Johns Hopkins University School of Medicine and is Director of the Arrhythmia Device Service at Johns Hopkins Hospital. Dr. Cheng is a Diplomate of the American Board of Internal Medicine and is board certified in Internal Medicine, Cardiovascular Diseases and Clinical Cardiac Electrophysiology. He is a member of the Heart Rhythm Society, American Heart Association and is recognized as a fellow of the American College of Cardiology. He actively participates in various committees with both the American College of Cardiology and the Heart Rhythm Society.

Dr. Tom Donner is an associate professor of medicine and the acting director of the Johns Hopkins Comprehensive Diabetes Center. His clinical and research interests include aggressive management of type 1 and type 2 diabetes, preserving beta cell function in patients with new onset type 1 diabetes, and the prevention of diabetes complications. Dr. Donner did his medical school training at the University of Virginia School of Medicine, and his Residency in Internal Medicine, Chief Residency in Medicine, and Endocrinology fellowship at the University of Maryland School of Medicine. Dr. Donner was the Director of the Joslin Diabetes Center affiliate at the University of Maryland Medical Center before joining Johns Hopkins University in 2010.

Franco Folli MD PhD is a Professor of Medicine, Department of Medicine, Division of Diabetes, University of Texas Health Science Center in San Antonio. His main reserch interests are understanding the pathogenic mechanisms of insulin resistance and insulin secretory defects in type 2 diabetes mellitus, the role of bariatric surgery for the treatment and prevention of type 2 diabetes mellitus and the development of multitarget therapeutic modalities for metabolic diseases. Recently he has developed a strong interest in the use of non-human primates, particularly baboons, to understand human disease, as well as to develop and identify new therapeutic approaches fpr insulin resistance and type 2 diabetes mellitus. He received his MD (magna cum laude) from the University of Milano, Italy, PhD from the University of Milano and University of Padova, Italy and Specialization in Diabetes and Metabolic Diseases from the University of Milano (magna cum laude). He completed post-doctoral training with Pietro De Camilli MD, Yale University and C. Ronald Kahn MD, Harvard Medical School, Joslin Diabetes Center, where he has also been a Visiting Investigator. He is the author/coauthor of over 130 journal articles and reviews, published in journals including The New England Journal of Medicine, Nature, Journal of Clinical Investigation, Proceedings of the National Academy of Science (USA), Journal of Biological Chemistry, Gastroenterology, Diabetes.

Dr. Foody works nationally and internationally to prevent cardiac disease and promote cardiac rehabilitation. She has a particular focus on women and heart disease, and her research has focused on identifying and promoting clinical strategies that prevent adverse cardiovascular events in people with and without coronary artery disease. Dr. Foody is a Fellow of the American College of Cardiology and the American Heart Association, and is the Chairperson of the Boston Sister to Sister Community Council. She attended the University of Chicago Pritzker School of Medicine, completed her residency at Brigham and Women’s Hospital, and completed her fellowship at the Cleveland Clinic Foundation. Dr. Foody regularly contributes to Journal Watch Cardiology as well as several other publications.

Dr Ezekowitz is an internationally known cardiologist with special expertise in echocardiology, thrombosis and atrial fibrillation. He has published over 200 peer reviewed articles and book chapters. A resident of Villanova, Dr. Ezekowitz was previously the June F. Klinghoffer Professor of Medicine (Cardiovascular) and Chairman of the Department of Medicine at Drexel University College of Medicine (formerly Hahnemann). He received his MD from the University of Cape Town in South Africa, his D. Phil. (PhD) from the Imperial College London University, and he was a Fellow in the Division of Cardiology at Johns Hopkins Hospital. Previous to his appointment at Drexel, Dr Ezekowitz had been Professor of Medicine in Cardiology at the Yale University School of Medicine. At Yale, he also served as the Director of the Cardiovascular Thrombosis Research Laboratory, the Chief of the Cardiovascular Section at West Haven VA Medical Center, and the Director of the Medical School Clinical Trials Office.

C. Michael Gibson, MS, MD, FACC is an Interventional Cardiologist and Chief of Clinical Research in the Division of Cardiology at Harvard’s Beth Israel Deaconess Medical Center. He received his masters and medical degree from the University of Chicago and was an Intern, Resident, and Chief Resident at the Brigham and Women’s Hospital, Harvard Medical School. He received his training as an Interventional Cardiologist and served as Director of the Coronary Care Unit at Beth Israel Hospital, Harvard Medical School. Additionally, Dr Gibson has served as Vice Chairman of Medicine for Clinical Research and as Director of Invasive Cardiology at Allegheny General Hospital, as well as Associate Chief of Cardiology, Chief of Interventional Cardiology, and Director of the Cardiac Catheterization Laboratory at the University of California, San Francisco. Dr Gibson’s work has been presented in over 1000 manuscripts, review articles, abstracts, textbooks, trial summaries, and textbook chapters.

Robert Giugliano is currently an Associate Physician in the Cardiovascular Division at the Brigham and Women’s Hospital and Assistant Professor in Medicine at Harvard Medical School. He graduated summa cum laude and phi beta kappa, majoring in mathematics at Dartmouth College, and received his medical degree at Harvard Medical School. Dr Giugliano completed his internship, residency, and chief residency in Los Angeles at Cedars-Sinai Medical Center, an affiliate hospital of UCLA, and then returned to Boston as a cardiology fellow at the Massachusetts General Hospital. In 1996, Dr Giugliano joined the Brigham and Women’s Hospital as a Research Fellow in Medicine working with the Thrombolysis in Myocardial Infarction (TIMI) Study Group under the direction of Eugene Braunwald, and completed a masters of science degree in epidemiology at the Harvard School of Public Health. In 1997, he joined the faculty in the cardiovascular division of the Brigham and Women’s Hospital and has served as the principal investigator for 8 multicenter clinical trials as part of the TIMI Study Group.

Dr. Michael M. Givertz's clinical research interests include the role of nitric oxide and oxidative stress in myocardial failure and the role of endothelia in pulmonary hypertension. Dr. Givertz's research also focuses on the development of novel, non-invasive tools to assess cardiac function and guide therapy.

Samuel Z. Goldhaber is Professor of Medicine at Harvard Medical School. He is a staff cardiologist at Brigham and Women’s Hospital (BWH), in Boston, where he practices general cardiology, attends to patients in the Coronary Care Unit, and oversees the BWH Thromboembolism Consultation Service. Dr Goldhaber is Founder and Director of the Anticoagulation Service at BWH, which cares for about 1,500 patients. He is also Director of the BWH Venous Thromboembolism Research Group. Dr Goldhaber received his AB from Harvard College and his MD from Harvard Medical School. He completed his postgraduate training in internal and cardiovascular medicine at the Peter Bent Brigham Hospital (now BWH). Dr Goldhaber is a member of the Program Organizing Committee for the International Society on Thrombosis and Haemostasis. In 2002, he was appointed to the organization’s Council on Thrombosis and the World Federation of Cardiology. In 2004, he was named the Eberhard Mammen Lecturer in Clinical Coagulation Science.

Antonio M. Gotto Jr., MD, DPhil, is the Stephen and Suzanne Weiss Dean of, and a professor of medicine at, Weill Medical College of Cornell University in New York City. He is also the Cornell University provost for medical affairs. Previously, at Baylor College of Medicine in Houston, Texas, he was the Bob and Vivian Smith Professor and chairman of the Department of Medicine, scientific director of the DeBakey Heart Center, and holder of the JS Abercrombie Professor Chair for Atherosclerosis and Lipoprotein Research. He also served as chief of the Internal Medicine Service at the Methodist Hospital in Houston. Dr. Gotto's postgraduate work included doctoral studies at Oxford University in England as a Rhodes Scholar, and residency training at the Massachusetts General Hospital in Boston, Massachusetts. As a lifelong supporter of educational efforts aimed at cardiovascular risk reduction, Dr. Gotto has been national president of the American Heart Association and president of the International Atherosclerosis Society.

Dr. Ishman received her medical degree from Rush Medical College in Chicago. She completed an internship in surgery and a residency in otolaryngology at the Medical College of Wisconsin. She then completed a fellowship in pediatric otolaryngology at Johns Hopkins. During her residency and fellowship, she underwent additional training in adult and pediatric sleep medicine at both the Johns Hopkins School of Medicine and at the Medical College of Wisconsin. Dr. Ishman is an appointed member of the Sleep Medicine and the Pediatric Otolaryngology Committees for the American Academy of Otolaryngology-Head & Neck Surgery. She also serves as a member of the clinical advisory board of the Cornelia de Lange Syndrome Foundation, Inc. Currently, Dr. Ishman is an assistant professor in the Department of Otolaryngology - Head & Neck Surgery. Her primary clinical area of interest is the medical and surgical treatment of pediatric and adult sleep disorders.

Peter H. Jones, MD, FACP, is Associate Professor of Medicine in the Section of Atherosclerosis and Lipid Research at Baylor College of Medicine and Medical Director for The Methodist Weight Management Center, Houston, Texas. He earned his medical degree at Baylor College of Medicine, completed his internship and residency at Baylor Affiliated Hospitals, and was Chief Medical Resident at Ben Taub General Hospital, also in Houston. Dr. Jones is board certified in Internal Medicine and by the American Board of Clinical Lipidology. A member of professional organizations, including the Texas Medical Association and the American College of Physicians, Dr. Jones was a steering committee member for the Air Force Coronary Atherosclerosis Prevention study from 1989 to 1998 and is a fellow of the Council on Atherosclerosis and Thrombosis of the American Heart Association. Also, he is a board member and served as President (2005-2006) for the National Lipid Association.

Dr. Jones, MD, FACC, ABCL, is Assistant Professor of Medicine, Division of Cardiology at Johns Hopkins University School of Medicine. He serves as Director of Inpatient Cardiology in the Division of Cardiology and faculty of the Ciccaroni Center for the Prevention of Heart Disease at Johns Hopkins Hospital in Baltimore, Maryland. Dr. Jones completed his undergraduate training at Tufts University. He received his MD from Hahnemann University (now Drexel University). His residency and fellowship were completed at Johns Hopkins Hospital. While his research interests include lipids and cardiovascular risk stratification, Dr. Jones’ clinical interests include general as well as preventive cardiology and cardiovascular imaging.

Dr. Kalyani is Assistant Professor of Medicine in the Division of Endocrinology. She moved to Baltimore after graduating from Harvard College and completed her medical degree at the Johns Hopkins University School of Medicine, where she also trained in internal medicine and endocrinology. During this time, she developed an interest in diabetes and now, as part of our faculty, sees patients regularly in the Diabetes Center. As part of our staff, Dr. Kalyani sees patients with all types of diabetes. She is an active researcher and is currently involved in studies exploring accelerated muscle loss as a complication of diabetes with aging. In addition to her clinical and research activities, Dr. Kalyani has been involved in the Trinidad and Tobago Health Science Initiative, a project that works with local physicians to improve the quality of diabetes care for this country. In addition, Dr. Kalyani serves as a consulting endocrinologist to the Pancreatic Islet Transplant program.

Industry Session Speaker

Dr. Peter Kwiterovich is chief of the Lipid Research and Atherosclerosis Division, Director of the Johns Hopkins Lipid Clinic, and Professor of Pediatrics and Medicine at the Johns Hopkins School of Medicine. In addition, Dr. Kwiterovich is Chief of the Lipid Research/Atherosclerosis Unit at the Johns Hopkins University School of Medicine, Director of The Johns Hopkins Lipid Clinic, and Director of The Johns Hopkins Physicians Lipid Disorders Training Center. He was the Director and principal investigator for The Johns Hopkins Coronary Artery Disease Study and the principal investigator for the National Health and Nutrition Education Survey (NHANES). He is currently a principal investigator for the Triad Heart Study, the Adolescent Diet, Hormones and Breast Cancer Susceptibility Study and the AIM-HIGH Study. Dr. Kwiterovich was also the Scientific Co-Founder and President of Lipid Therapeutics, Inc. Dr. Kwiterovich is a leading scholar in the field of lipid research since its inception and is a recognized leader in the field both nationally and internationally. He was an inaugural member of the National Cholesterol Education Program for Cholesterol in Children and Adolescents and more recently Chair of the Lipid Component of the National Heart Lung and Blood Institutes Panel on Cardiovascular Disease Risk Factors in Children.

Industry Session Speaker

Dr. Daniel Lenihan is Professor of Medicine and Director of the Clinical Research Program at Vanderbilt University Medical Center. His research interests range from pathophysiology of heart failure to hemodynamics, with a recent focus on early detection and treatment of cardiac toxicity during chemotherapy. He has been developing a cardiology research database within his department that will be a tool to better understand and describe the best possible care for patients undergoing cancer therapy. He is also pursuing the development of an active working group whose focus will be on how the disciplines of cardiology and oncology overlap and which mechanisms can be explored to improve patient care. He received his MD from the University of Tennessee School of Medicine, and is board certified in cardiology, nuclear cardiology and internal medicine.

Dr. Jack Lewin is the chief executive officer of the American College of Cardiology (ACC), a position he has held since November 2006. Under his leadership, ACC has aspired to contribute greatly to national leadership in advocacy related to expanding access to care for uninsured persons, and in reforming Medicare, Medicaid, and the financing and delivery of quality health care. These efforts are part of ACC's mission to promote ‘heart health' and reductions in cardiovascular morbidity and mortality worldwide. Prior to coming to ACC, Dr. Lewin was the chief executive officer of the California Medical Association and its various subsidiary companies. Dr. Lewin was also formerly Hawaii's Director of Health from 1986-1994, a role through which he helped Hawaii achieve near-universal access to health care and revitalize statewide public health systems. In Hawaii, he was also the chief executive officer of the statewide 13-facility Community Hospital System.

Peter Libby, MD, is the Chief of Cardiovascular Medicine at the Brigham and Women’s Hospital in Boston, Massachusetts. He also serves as the Mallinckrodt Professor of Medicine at Harvard Medical School. Dr. Libby directs the D.W. Reynolds Cardiovascular Clinical Research Center at Harvard. His current major research focus is the role of inflammation in vascular diseases such as atherosclerosis. Dr. Libby has received numerous awards and recognitions for his research accomplishments. His areas of clinical expertise include general and preventive cardiology. An author and lecturer on cardiovascular medicine and atherosclerosis, Dr. Libby has published extensively in medical journals including Circulation, Journal of Clinical Investigation, Proceedings of the National Academy of Sciences, New England Journal of Medicine, and Nature. He is Editor-in-Chief of the Eighth edition of Braunwald’s Heart Disease. Dr. Libby has also contributed the chapter on the pathogenesis, treatment, and prevention of atherosclerosis to Harrison’s Principles of Internal Medicine. He has held numerous visiting professorships and has been selected to deliver over 60 named or keynote lectures throughout the world.

Dr. Lloyd-Jones earned his BA from Swarthmore College in 1986, majoring in History (with a focus on American diplomatic history). He received his MD degree from Columbia University College of Physicians and Surgeons in 1991, and a Master of Science degree in Epidemiology from the Harvard School of Public Health in 2001. He was an intern and resident in Internal Medicine at Massachusetts General Hospital in Boston, and served as Chief Medical Resident in 1995-1996. After his cardiology fellowship at MGH, he joined the staff as an attending cardiologist, and was an Instructor and then Assistant Professor of Medicine at Harvard Medical School. He joined the National Heart, Lung, and Blood Institute’s Framingham Heart Study as a research fellow in 1997, and became a staff research associate in 1999. In this capacity, he also held an appointment as Adjunct Assistant Professor of Medicine at Boston University School of Medicine. He joined the Department of Preventive Medicine at Northwestern University in 2004, and is an avid Yankees (and now Cubbies) fan. He is currently an Associate Professor of Preventive Medicine and Medicine (Cardiology) and the Director of the Program in Cardiovascular Risk Estimation, Communication, and Prevention.

Dr. Mahmud is an interventional cardiologist who performs angioplasty and stenting for blocked arteries to the heart, kidneys, legs and brain. His research interests include the study of medical therapy, gene therapy, stem cell therapy, and device therapy for patients with heart and vascular disease. Dr. Mahmud is Associate Professor of Medicine at UCSD and Director, Cardiovascular Catheterization Laboratory and Interventional Cardiology at UCSD Medical Center. He has been honored with the Laennec Society Young Clinician Award from the American Heart Association and chosen as one of America's Top Physicians each year from 2003 through 2009 by the Consumer Research Council. He is a Fellow of the Society of the Royal College of Physicians and Surgeons of Canada, a Fellow of the Society for Cardiac Angiography and Interventions, and a Fellow of the American College of Cardiology. In 2009, Dr. Mahmud was also named one of San Diego’s "Physicians of Exceptional Excellence" by the San Diego County Medical Society.

Industry Session Speaker

Dr. Seth S. Martin is a 1st year Cardiology Fellow in the Division of Cardiology at The Johns Hopkins Hospital in Baltimore, Maryland. He is also an investigator in the Ciccarone Center for the Prevention of Heart Disease. He graduated Phi Beta Kappa from Washington and Lee University where he played varsity tennis. Dr. Martin went on to receive his medical degree from the University of Pennsylvania School of Medicine, where he was awarded the Gertrude M. & Ezra M. Eisen Prize for outstanding performance in cardiology rotations and research. Dr. Martin did his Internal Medicine training at Duke University Medical Center where he was twice awarded with a Robert M. Califf Resident Research Award. Dr. Martin’s research focuses on lipids and lipoproteins, overall cardiovascular risk assessment, and the prevention of atherosclerotic vascular disease disease.

Roxana Mehran, MD, FACC, FACP, FCCP, FESC, FAHA, FSCAI is Professor of Medicine and Director of Interventional Cardiovascular Research and Clinical Trials at the Zena and Michael A. Weiner Cardiovascular Institute at Mount Sinai School of Medicine. Dr. Mehran completed her training in internal medicine at the University of Connecticut, where she was also a Chief Medical Resident, before continuing with Fellowships in Cardiovascular Disease and Interventional Cardiology at Mount Sinai Medical Center. Dr. Mehran is internationally recognized for her work as a clinical trial specialist with complex data analyses and outcomes research within the field of interventional cardiology and for her experience and expertise in working with regulatory agencies to conduct clinical trials. Her research interests expand from mechanisms of restenosis to treatment and prevention of acute kidney injury in cardiac patients, as well as advancing treatments for acute coronary syndromes and acute myocardial infarction.

Dr. Miller serves as Professor of Medicine in the Division of Cardiology and Professor of Epidemiology and Preventive Medicine at the University of Maryland School of Medicine. In addition, he is Director, Center for Preventive Cardiology for the University of Maryland Medical System and Staff Physician at the Veterans Affairs Medical Center in Baltimore. His major research interests are disorders of lipid and lipoprotein metabolism, molecular studies of HDL cholesterol, triglycerides and the postprandial response to dietary fat, nontraditional coronary risk factors and clinical trials to reduce atherosclerosis. He received his B.A. degree from Rutgers College and his M.D. from The Robert Wood Johnson Medical School in New Jersey. Following a medical residency at the University of Cincinnati Medical Center, he completed two fellowships at The Johns Hopkins Hospital in Baltimore, one in lipoprotein metabolism and the second in cardiovascular disease. Dr. Miller is a Fellow of the American College of Cardiology and the American Heart Association Council on Arteriosclerosis.

Dr. Javid Moslehi graduated from Johns Hopkins University and University of Connecticut School of Medicine. During medical school, he won the prestigious Sarnoff Fellowship, allowing him to study cancer genetics at the Dana-Farber Cancer Institute for one year. He completed a three year internal medicine residency at Johns Hopkins Hospital, followed by both cardiology and vascular medicine fellowships at Brigham and Women’s Hospital and Harvard Medical School. He then started a post-doctoral fellowship at the Dana-Farber Cancer Institute, focusing on the role of angiogenesis (formation of new blood vessels) in the heart. He has received a career development award from the National Institutes of Health for this work. Dr. Moslehi is interested in cardiovascular health of the cancer patient undergoing cancer treatment. He is particularly interested in the potential cardiovascular complications of novel molecular targeted therapies and is interested to establish treatment strategies for these complications.

Dr. Daniel Munoz is a fellow in the Division of Cardiology at Johns Hopkins University. Dr. Munoz completed his residency in the Department of Medicine at the Johns Hopkins University School of Medicine. He obtained his medical degree from the Johns Hopkins School of Medicine (class of 2005) and also has a Master's in Public Administration from Harvard University's John F. Kennedy School of Government where he concentrated on health economics and public policy. Dr. Munoz has a Bachelor of Arts in Economics from Princeton University where he graduated with honors. He spent the summers of 1999 and of 2001 working in the United States Senate in the Health Policy Office of Senator Edward M. Kennedy in Washington, DC. He is a frequent contributor to Hopkins Medicine Magazine and The Baltimore Sun. Dr. Munoz is first generation Colombian-American, equally fluent in English and Spanish and currently resides in Baltimore, Maryland.

Industry Session Speaker: Dr. Muntendam has been President and CEO of BG Medicine since November 2004. He is a biopharmaceutical and healthcare executive with in-depth business experience ranging from early stage ventures to multinational corporations.

Dr. Musi received his medical degree in 1995 from the Universidad Anahuac in Mexico City. He finished his internship and residency in internal medicine at the University of Miami-Jackson Memorial Medical Center in 1998. Dr. Musi then completed a clinical fellowship in endocrinology and metabolism at the Joslin Diabetes Center-Beth Israel Deaconess Medical Center and Harvard Medical School in 2001. He then joined the Harvard faculty. Recruited to the Health Science Center in 2003, he served as associate director for clinical research at the Texas Diabetes Institute, located in the University Center for Community Health on San Antonio’s West Side. He is board certified in internal medicine and endocrinology and metabolism. His research expertise is in aging, insulin resistance and exercise physiology. He is principal investigator on grants from the National Institutes of Health, the American Federation for Aging Research and the American Diabetes Association. Dr. Musi recently was named director of the GRECC and is a member of the Barshop Institute.

Dr. Nallamothu is an interventional cardiologist and health services researcher at the University of Michigan and Ann Arbor VA Medical Center. His primary research interest is in developing population-based approaches to optimize the delivery of specialized cardiac procedures, like coronary stenting. He participated as a steering committee member for the D2B Alliance, a large quality improvement effort focused on improving the timeliness of primary PCI, as well as numerous research and quality improvement committees within the ACC, AHA, and the VA Healthcare System.

Dr. Nambi's clinical research interests are in the prevention of cardiovascular disease and include the use of biomarkers and imaging in risk prediction and management of these patients with specific interests in peripheral and multi-bed atherosclerotic disease. DR Nambi will be studying patients with peripheral and multi-bed atherosclerotic disease to find novel biomarkers such as those associated with inflammation which may potentially help in better risk prediction and hence management of these patients. In addition he is interested in the use of ultrasound imaging for the evaluation of atherosclerosis with the help of initmal medial thickness and other novel ultrasound based imaging techniques. He will also be working on studies that use novel pharmacologic interventions in the management of atherosclerosis and focus on studies that utilize imaging for the assesment and evaluation of the same.

Dr. Richard W. Nesto is Chairman, Department of Cardiovascular Medicine at Lahey Clinic Medical Center in Burlington, Massachusetts, and Associate Professor of Medicine at Harvard Medical School, Boston.  Previously, he was Director of Clinical Research in Cardiology and Co-Director of the Institute for Prevention of Cardiovascular Disease at Beth Israel Deaconess Medical Center in Boston.  Dr. Nesto’s major interest involves heart disease in patients with diabetes mellitus.  His contributions have lead to a wider appreciation that coronary artery disease has unique features and that treatment of coronary syndromes in these patients requires a specialized approach. He has conducted numerous studies evaluating the impact of diabetes on cardiac structure and function.  He is a Co-principal Investigator of BARI-2D, an NIH trial evaluating various treatment strategies to improve survival in patients with diabetes and coronary artery disease.

Dr. Anju Nohria graduated from Harvard Medical School and did her residency in Internal Medicine at Yale New Haven Hospital in New Haven, CT. She did her sub-specialty training in cardiology at Brigham and Women's Hospital in Boston, MA and has particular expertise in heart failure and transplantation. She has done extensive research on the management of acute decompensated heart failure and is currently focused on evaluating prevention and treatment strategies in patients who develop cardiomyopathy and other cardiovascular complications as a consequence of cancer therapy. From a clinical perspective, she has a joint appointment in the advanced heart disease section at Brigham and Women's Hospital and in the cancer survivorship section at Dana Farber Cancer Institute. In this capacity, she sees patients both in the Shapiro Cardiovascular Center at Brigham and Women's Hospital and in the Lance Armstrong Survivorship clinic at Dana Farber Cancer Institute.

Michelle O’Donoghue, MD MPH, is an Associate Physician in the Cardiology Division of Brigham and Women’s Hospital, an Affiliate Physician in the Cardiology Division of Massachusetts General Hospital and an Instructor in Medicine at Harvard Medical School in Boston, Massachusetts. She is a member of the Thrombolysis in Myocardial Infarction (TIMI) Study Group. Dr. O’Donoghue’s primary research focus is the design and conduct of multicenter clinical trials for patients with stable and unstable heart disease. Additional clinical research interests include the evaluation of established and novel biomarkers, the study of women and heart disease and the development of novel therapeutics in the management of acute coronary syndromes. Dr. O’Donoghue earned her medical degree from Columbia University College of Physicians and Surgeons in New York. She completed her residency in internal medicine and fellowship in cardiovascular medicine at Massachusetts General Hospital in Boston. She subsequently completed a Masters in Public Health degree at the Harvard School of Public Health.

William W. O'Neill, M.D., FACC, has been the director of the division of Cardiovascular Disease at William Beaumont Hospital, Royal Oak, since December 1987, co-director of the Beaumont Heart Center, Royal Oak, since it opened in May, 1999, and was appointed Corporate Chief of Cardiology, William Beaumont Hospitals, Royal Oak and Troy, in 2002. Dr. O’Neill was named Vice Chair Department of Internal Medicine for Research in January 2003. Prior to joining Beaumont, he was director of the cardiac catheterization laboratory at the University of Michigan in Ann Arbor and an associate professor of medicine at the University of Michigan Medical School. A graduate of Wayne State University School of Medicine, Dr. O'Neill completed a cardiology fellowship at the University of Michigan Hospital. He is certified in interventional cardiology and cardiovascular disease by the American Board of Internal Medicine. An author of more than 35 book chapters, 230 articles, 330 abstracts, Dr. O’Neill provides frequent interviews to local and national media about interventional cardiology.

Industry Session Speaker

Jeffrey J. Popma, MD, (ACCF) is the Director, Innovations in Interventional Cardiology and a Senior Attending Physician at Beth Israel Deaconess Medical Center and an Associate Professor of Medicine at Harvard Medical School in Boston, Massachusetts. He was also Director of Interventional Cardiology, Director of the Interventional Cardiology Fellowship Training Program, and Director of the Angiographic Core Laboratory at Brigham and Women’s Hospital from 1998 to 2007 Dr. Popma is the Past-President of the Society for Cardiac Angiography and Intervention. He is currently the Co-Chair of the ACC Interventional Council and Chairman of the ACC Cardiac Catheterization Committee. Dr. Popma has over 300 peer reviewed manuscripts published. He also directs the BWH Angiographic Core Laboratory and is principal investigator for over 65 ongoing multicenter device studies.

Naresh M. Punjabi, MD, PhD is an Associate Professor of Medicine and Epidemiology in the Division of Pulmonary and Critical Care Medicine at the Johns Hopkins University School of Medicine. He received his undergraduate education in Biomedical Engineering from Northwestern University and his MD from the University of Chicago (Pritzker School of Medicine) in 1991. He completed his post-doctoral training in Internal Medicine, Pulmonary/Critical Medicine, and Sleep Medicine all at the Johns Hopkins University School of Medicine in Baltimore, Maryland. His current research focuses on the clinical and population epidemiology of sleep apnea with a particular emphasis on outcomes including insulin resistance, type 2 diabetes mellitus, and cardiovascular disease. Ongoing work in his laboratory is examining intermediate pathways through which intermittent hypoxia and sleep fragmentation in sleep apnea alter normal glucose homeostasis. He has been one of the principal investigators for the multi-center Sleep Heart Health Study examining the longitudinal effects of sleep apnea on hypertension, cardiovascular disease, and mortality.

Dr. Rader is the Cooper-McClure Professor of Medicine and is Professor of Pathology and Pharmacology at the University of Pennsylvania School of Medicine. He is Director of the newly created Clinical and Translational Research Center and Associate Director of Penn’s Institute for Translational Medicine and Therapeutics. He is also the Director of Preventive Cardiovascular Medicine and Lipid Clinic and the Director of the Lipid-Atherosclerosis Research Unit. Dr. Rader’s basic research laboratory focuses on genetic and pharmacologic regulation of lipoprotein metabolism and atherosclerosis, and he directs a translational research program focusing on human genetics of lipid disorders and atherosclerosis and novel approaches to treatment of dyslipidemia and regression of atherosclerosis. He has a particular interest in HDL metabolism, factors and genes involved in its regulation, the causal nature of the relationship of HDL metabolism to atherosclerosis, and novel approaches to targeting HDL metabolism and reverse cholesterol transport in the treatment, prevention, and regression of atherosclerosis.

Dr. Ratchford completed her internal medicine residency at Columbia University Medical Center. She has been active with the Society for Vascular Medicine since 2003. She currently serves at the Director of the Johns Hopkins Center for Vascular Medicine within the Division of Cardiology at Johns Hopkins University School of Medicine. Dr. Ratchford has an active clinical practice that focuses on the non-invasive diagnosis and medical management of vascular conditions such as those described above. As a vascular medicine specialist and an internist, Dr. Ratchford’s goals of treatment include aggressive risk factor modification, lifestyle changes, and often a formal exercise program. She treats vascular risk factors such as diabetes, hypertension, and high cholesterol with additional focus on smoking cessation, exercise, and weight loss. She works closely with the patient and his or her other physicians to achieve treatment goals in order to prevent disease progression and to improve quality of life.

Dr. Ridker is the Eugene Braunwald Professor of Medicine at the Harvard Medical School and directs the Center for Cardiovascular Disease Prevention, a translational research unit at the Brigham and Women’s Hospital that focuses on the molecular and genetic epidemiology of cardiovascular diseases. Dr. Ridker’s primary research brings together classical tools of large-scale, population based epidemiology with emerging genetic and molecular techniques designed to improve our ability to predict and prevent thrombotic occlusion. Particular areas of interest involve molecular and genetic determinants of hemostasis, thrombosis, and inflammation with a focus on “predictive medicine”, early disease diagnosis, and the underlying causes and prevention of acute coronary syndromes. While much of Dr Ridker’s work has focused on inflammatory mediators of vascular risk and the use of inflammatory biomarkers such as CRP to improve cardiovascular risk prediction, with a strong background in statistical methods, clinical trial methodology, and study design, Dr Ridker also has served as the Principal Investigator or Study Chairman of multiple clinical trials funded by federal and non-federal sources including PREVENT, PRINCE, LANCET, VAL-MARC and the recently completed JUPITER trial being conducted in 26 countries. With regard to genetic epidemiology, Dr Ridker is currently Principal Investigator of the Women’s Genome Health Study, a 27,000 participant genome wide association study based upon participants in the NIH-funded Women’s Health Study that is designed to ascertain the genetic determinants of a wide variety of vascular disorders as well as lipid and inflammatory intermediate phenotypes. Since 2003, Dr Ridker has been a Reynolds Investigator at the Brigham and Women’s Hospital and received additional research support from the Doris Duke Charitable Foundation and the Leducq Foundation.

Marc S. Sabatine, MD, MPH, is an Associate Physician in the Cardiovascular Medicine Division at Brigham and Women’s Hospital, an Investigator in the Thrombolysis in Myocardial Infarction (TIMI) Study Group, and an Assistant Professor of Medicine at Harvard Medical School. Dr. Sabatine graduated magna cum laude from Harvard College and received his medical degree magna cum laude from Harvard Medical School. He subsequently did his Internal Medicine residency, Chief Residency, and Cardiology fellowship at the Massachusetts General Hospital. During his research fellowship, he received a Master of Public Health degree from the Harvard School of Public Health. Dr. Sabatine is board certified in Internal Medicine and Cardiology and attends on the general cardiology services and in the coronary care unit at both Brigham and Women’s Hospital and the Massachusetts General Hospital. Dr. Sabatine’s research focuses on optimizing the treatment of patients with acute coronary syndromes through (1) clinical trials of novel pharmacotherapies, (2) use of existing biomarkers for risk stratification and discovery of novel biomarkers using proteomics and metabolomics, and (3) application of pharmacogenetics to cardiology. Dr. Sabatine has a particular interest in antiplatelet and anticoagulant therapies.

Dr. Shapiro is currently Professor of Medicine at Johns Hopkins University and director of the non-invasive labs at Johns Hopkins Bayview Medical Center. He trained at Johns Hopkins for medical school, Johns Hopkins in internal medicine, and the University of Chicago in Cardiology. He has long term interests in cardiac imaging, left ventricular deformation, and left ventricular diastolic function, and has published more than 100 papers on these subjects. His original work utilized echocardiography, then cardiac MRI, and now cardiac CT. Currently, he is devoting the majority of his time toward teaching and research in cardiac CT angiography.

Laurence S. Sperling, M.D., FACC, FACP is the Founder and Director of Preventive Cardiology at the Emory Clinic and Co-Director of the Cardiovascular Disease Fellowship Program at Emory. He is currently a Professor of Medicine (Cardiology) at the Emory University School of Medicine. He was awarded The American College of Cardiology Harry B. Graf Career Development Award for Heart Disease Prevention and The American Heart Association Council on Clinical Cardiology Scholarship for Physical Activity and Public Health in 2001. Dr. Sperling is originally from New York. He received his undergraduate degree from Emory College where he was accepted into Emory University School of Medicine’s Early Acceptance Program as a college sophomore. He graduated with his M.D. in 1989, and subsequently completed 8 additional years of training at Emory including a residency in internal medicine, chief resident year at Emory University Hospital, an NIH-supported research fellowship in molecular and vascular medicine, and a clinical fellowship in cardiovascular diseases.

Dr. Gregg Stone is Activity Director of Interventional Cardiology at CardioCareLive. Gregg W. Stone, MD, FACC, FSCAI is a Professor of Medicine at Columbia University, director of Cardiovascular Research and Education of the Center for Interventional Vascular Therapies at Columbia University Medical Center, and the Cardiovascular Research Foundation in New York, NY. Dr. Stone has served as the national or international principal investigator for more than 40 national and international multicenter randomized trials, has authored more than 1000 book chapters, manuscripts and abstracts published in the peer-reviewed literature, and has delivered thousands of invited lectures around the world. Dr. Stone's areas of expertise include interventional therapies of acute coronary syndromes and myocardial infarction; drug eluting stents; adjunct pharmacology; percutaneous heart valves, new device angioplasty including distal embolic protection, thrombectomy, vascular brachytherapy and stent grafts; intravascular ultrasound imaging; saphenous vein graft therapies; chronic total occlusions; vulnerable plaque; contrast nephropathy; clinical trial design; and regulatory issues.

Allen J. Taylor, MD, specializes in Cardiac Non-Invasive Imaging. Dr. Taylor joined Washington Hospital Center in 2008, as the director of Advanced Cardiovascular Imaging. Dr. Taylor also serves as a professor of Medicine at the Uniformed Services University School of Medicine in Bethesda, Md. He retired from the United States Army in 2008, after serving for 20 years at Walter Reed Army Medical Center as director of Cardiovascular Research, director for the training program in Cardiovascular Disease and chief of the Cardiology Service. Dr. Taylor’s extensive lectures and publications in his field include more than 160 publications in the areas of Imaging, high cholesterol prevention (Lipids and Prevention), in journals including Circulation, The Journal of the American Medical Association and The New England Journal of Medicine.

Dr. Underberg is a Clinical Assistant Professor of Medicine in the Division of General Internal Medicine at NYU Medical School and is a member of the executive committee of the Division of General Internal Medicine. His clinical focus is Preventive Cardiovascular Medicine. He is an American Society of Hypertension Certified Specialist in Clinical Hypertension, a fellow of the Society for Vascular Medicine & Biology, and a North American Menopause Society Certified Menopause Practitioner. Dr. Underberg is the founder and President of the New York Preventive Cardiovascular Society and a member of the Board of Directors of the Northeast Chapter of the National Lipid Association. He graduated from Yale University with a BS and MS and from the University of Pennsylvania Medical School. His internship and residency were completed at Bellevue Hospital Medical Center. He is currently involved in several clinical trials in the areas of hypertension, lipids, diabetes and cardiovascular disease.

Howard Weintraub, MD, FACC, is the Clinical Director of Center for the Prevention of Cardiovascular Disease at NYU Medical Center. He has been a consultant for several organizations and has been a Cardiologist for the National Football League. Dr. Weintraub has written textbook chapters on evaluation and treatment of patients prior to noncardiac surgery. He has also authored several articles on endothelial function and participated in clinical trials for treatment of lipid disorders. Dr. Weintraub has been named to the editorial board of Cardiology Review. He is one of the senior faculty in Vascular Biology Working Group and the Coalition for the Advancement of Cardiovascular Health, and is also a consultant to several pharmaceutical companies.

Matthew R. Weir, MD, is attending physician and Director of the Division of Nephrology in the Department of Medicine at the University of Maryland Hospital, Baltimore. He is also Professor of Medicine at the University of Maryland School Of Medicine. Dr. Weir currently reviews manuscripts for more than 20 major medical journals, including the American Journal of Kidney Disease, the Journal of the American Society of Nephrology, and Archives of Internal Medicine. He is on the editorial board of eight journals and is Section Editor of Current Hypertension Reports and Current Opinion in Hypertension and Nephrology. He has three active NIH supported grants from NIDDK. In addition, he is a member of numerous associations, including the American Society of Nephrology, the National Kidney Foundation, the American Heart Association, and the American Society of Transplantation. Dr. Weir received his medical degree from the University of Virginia, Charlottesville. He completed his internship and residency programs in medicine at the Waterbury and Yale-New Haven Hospitals in Connecticut, and completed his nephrology training at the Brigham and Women’s Hospital, Harvard Medical School, in Boston, Massachusetts. He then moved to the University of Maryland where he has been a full time faculty member since 1983.

Dr. Stephen D. Wiviott is a graduate of University of Pennsylvania in 1990 and Harvard Medical School (Honors) in 1996. He served as a Medical House Officer and Chief Medical Resident at Brigham and Women’s Hospital. Following his medical residency training, he served as a Cardiology Fellow at Johns Hopkins Hospital and as a Cardiovascular Research Fellow with the TIMI Study Group with the Cardiovascular Division of Brigham and Women’s Hospital. After completion of his training he has joined the faculty of the Cardiovascular Division of Brigham and Women’s Hospital and serves as Assistant Professor of Medicine at Harvard Medical School, and an investigator with the TIMI Study Group. Dr. Wiviott is a general Cardiologist on staff at Brigham and Women’s Hospital attending on the Coronary Care Unit, and the inpatient Cardiology and Cardiology Consultation services. He is active in clinical teaching of Cardiology Fellows, Internal Medicine Housestaff, and Harvard Medical Students.

Clyde W. Yancy, MD, has been named the Magerstadt professor and chief of the division of cardiology at Northwestern Memorial Hospital and Northwestern University Feinberg School of Medicine. Dr. Yancy's medical appointments include serving as associate director of clinical programs for the Bluhm Cardiovascular Institute. Most recently the medical director for Baylor Heart and Vascular Institute and the chief of cardiothoracic transplantation for Baylor University Medical Center in Dallas, Dr. Yancy is the immediate-past president of the American Heart Association (AHA). Dr. Yancy is board certified in internal medicine with a subspecialty in cardiovascular disease. He is a Fellow of the ACC, AHA, and ACP. He holds an associate editorship for the American Journal of Cardiology; associate editorial board for Congestive Heart Failure; and editorial board membership for The American Heart Journal and for Circulation. Dr. Yancy’s research interests include the broad areas of clinical congestive heart failure and heart transplantation.